Action Eli Lilly - LLY

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Dernier

767,76

Prix Achat

Prix Vente

Volume échangé

9 942 516

766,61 Fourchette du Jour 814,25

567,02 Plage de 52 semaines 972,53

Cap du marché

728,847B

Clôture Veille

757,54

Ouverture

813,33

Dernière Transaction

779.82

Dernière heure de transaction

Volume financier

US$ 7 825 299 672

VWAP

787,0543

Volume moyen (3 m)

3 675 472

Actions en circulation

949 315 694

Rendement du Dividende

0.78%

Ratio Cours sur Bénéfices

139,08

Bénéfice par action (BPA)

5,52

Chiffre d'affairess

34,12B

Bénéfice net

5,24B

Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer; Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology. Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer; Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.

Secteur

Pharmaceutical Preparations

Industrie

Pharmaceutical Preparations

Site Web

www.lilly.com

Siège social

Indianapolis, Indiana, USA

Fondé

Eli Lilly and Co est coté dans le secteur Pharmaceutical Preparations de la New York Stock Exchange avec le ticker LLY. Le dernier cours de clôture d'Eli Lilly était de US$757,54. Au cours de la dernière année, les actions de Eli Lilly ont été négociées dans une fourchette de prix de US$ 567,02 à US$ 972,53.

Eli Lilly compte actuellement 949 315 694 actions en circulation. La capitalisation boursière d'Eli Lilly est de US$719,14 milliard. Eli Lilly a un ratio cours/bénéfice (ratio PE) de 139.08.

Flux global

Baissier

Prime nette

-12M

Calls / Puts

109,71%

Ach. / Vent.

96,59%

OTM / ITM

64,51%

Sweeps Ratio

1,28%

FDA approves Zepbound® (tirzepatide) as the first and only prescription medicine for moderate-to-severe obstructive sleep apnea in adults with obesity

FDA approves Zepbound® (tirzepatide) as the first and only prescription medicine for moderate-to-severe obstructive sleep apnea in adults with obesity PR Newswire INDIANAPOLIS, Dec. 20, 2024...

Lilly's Kisunla™ (donanemab-azbt) Approved in China for the Treatment of Early Symptomatic Alzheimer's Disease

Lilly's Kisunla™ (donanemab-azbt) Approved in China for the Treatment of Early Symptomatic Alzheimer's Disease PR Newswire INDIANAPOLIS, Dec. 17, 2024 China is the fourth major market where...

Form 4 - Statement of changes in beneficial ownership of securities

Lilly and EVA Pharma announce regulatory approval and release of locally manufactured insulin in Egypt

Lilly and EVA Pharma announce regulatory approval and release of locally manufactured insulin in Egypt PR Newswire INDIANAPOLIS and CAIRO, Dec. 17, 2024 This milestone stems from the companies...

Lilly's Omvoh® (mirikizumab) recommended by CHMP for approval in the European Union for adults with moderately to severely active Crohn's disease

Lilly's Omvoh® (mirikizumab) recommended by CHMP for approval in the European Union for adults with moderately to severely active Crohn's disease PR Newswire INDIANAPOLIS, Dec. 13, 2024 The Phase...

Lilly's Imlunestrant, an Oral SERD, Significantly Improved Progression-Free Survival as Monotherapy and in Combination with Verzenio® (abemaciclib) in Patients with ER+, HER2- Advanced Breast Cancer

Lilly's Imlunestrant, an Oral SERD, Significantly Improved Progression-Free Survival as Monotherapy and in Combination with Verzenio® (abemaciclib) in Patients with ER+, HER2- Advanced Breast...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	-12.964	-1.66050998816	780.724	799.7826	752.395	3530136	773.15994692	CS
4	13.76	1.824933687	754	846.4629	740.01	3417240	787.67071499	CS
12	-127.24	-14.2167597765	895	937	711.4001	3675472	817.4624339	CS
26	-123.92	-13.8973622824	891.68	972.53	711.4001	3401682	854.26757874	CS
52	192.34	33.4260192555	575.42	972.53	567.02	3143150	801.70444552	CS
156	498.53	185.168814768	269.23	972.53	231.87	3027740	529.14356373	CS
260	635.27	479.485244169	132.49	972.53	116.55	3279313	372.45525342	CS

LLY - Frequently Asked Questions (FAQ)

What is the current Eli Lilly share price?

The current share price of Eli Lilly is US$ 767,76

How many Eli Lilly shares are in issue?

Eli Lilly has 949 315 694 shares in issue

What is the market cap of Eli Lilly?

The market capitalisation of Eli Lilly is USD 719,14B

What is the 1 year trading range for Eli Lilly share price?

Eli Lilly has traded in the range of US$ 567,02 to US$ 972,53 during the past year

What is the PE ratio of Eli Lilly?

The price to earnings ratio of Eli Lilly is 139,08

What is the cash to sales ratio of Eli Lilly?

The cash to sales ratio of Eli Lilly is 21,36

What is the reporting currency for Eli Lilly?

Eli Lilly reports financial results in USD

What is the latest annual turnover for Eli Lilly?

The latest annual turnover of Eli Lilly is USD 34,12B

What is the latest annual profit for Eli Lilly?

The latest annual profit of Eli Lilly is USD 5,24B

What is the registered address of Eli Lilly?

The registered address for Eli Lilly is 334 NORTH SENATE AVENUE, INDIANAPOLIS, INDIANA, 46204

What is the Eli Lilly website address?

The website address for Eli Lilly is www.lilly.com

Which industry sector does Eli Lilly operate in?

Eli Lilly operates in the PHARMACEUTICAL PREPARATIONS sector

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
VNCEVince Holding Corp	US$ 4,70 (69,06%)	1,06M
SRFMSurf Air Mobility Inc	US$ 3,33 (23,79%)	376,77k
BBBlackBerry Limited	US$ 3,685 (23,66%)	40,8M
ALURAllurion Technologies Inc	US$ 0,3439 (22,87%)	744,34k
CLWClearWater Paper Corporation	US$ 30,26 (22,46%)	3,5M
IIPRInnovative Industrial Properties Inc	US$ 73,50 (-22,91%)	3,15M
KUKEKuke Music Holding Limited	US$ 0,31 (-20,51%)	61,48k
NVONovo Nordisk	US$ 85,00 (-17,83%)	53,81M
CANGCango Inc	US$ 5,08 (-11,81%)	2,44M
BNEDBarnes and Noble Education Inc	US$ 9,965 (-10,31%)	1,55M
QBTSD Wave Quantum Inc	US$ 6,638 (4,21%)	124,42M
PFEPfizer Inc	US$ 26,36 (2,29%)	116,33M
APOApollo Global Management Inc	US$ 171,03 (0,83%)	94,52M
TAT&T Inc	US$ 22,75 (0,80%)	93,94M
FFord Motor Company	US$ 9,885 (1,49%)	87,66M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Eli Lilly and Co (LLY) Cours

Eli Lilly and Co (LLY)

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

À propos de Eli Lilly and Co

Flux d'options Eli Lilly (LLY)

Flux global

Baissier

Prime nette

-12M

Calls / Puts

109,71%

Ach. / Vent.

96,59%

OTM / ITM

64,51%

Sweeps Ratio

1,28%

LLY Dernières nouvelles

LLY - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application